相似文献
1
Immunoregulatory biological response modifiers: effect of cytokines on septic shock.
Mediators Inflamm. 1993;2(7):S5-S10. doi: 10.1155/S0962935193000675.
2
Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
Prog Clin Biol Res. 1991;367:141-59.
3
Interleukin-1, -6 and tumor necrosis factor-alpha release is down-regulated in whole blood from septic patients.
Acta Haematol. 1996;95(3-4):268-73. doi: 10.1159/000203895.
4
Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature.
Neth J Med. 1991 Aug;39(1-2):45-62.
5
[Cachectin or TNF (tumor necrosis factor): clinical implications].
Ann Fr Anesth Reanim. 1990;9(6):525-35. doi: 10.1016/s0750-7658(05)80224-2.
6
Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion.
Infect Immun. 1996 Mar;64(3):825-8. doi: 10.1128/iai.64.3.825-828.1996.
7
The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production.
Brain Behav Immun. 2004 Sep;18(5):476-84. doi: 10.1016/j.bbi.2003.12.001.
8
A cell wall component from pathogenic and non-pathogenic gram-positive bacteria (peptidoglycan) synergises with endotoxin to cause the release of tumour necrosis factor-alpha, nitric oxide production, shock, and multiple organ injury/dysfunction in the rat.
Shock. 2001 Feb;15(2):135-42. doi: 10.1097/00024382-200115020-00010.
9
Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis.
J Lab Clin Med. 1996 Dec;128(6):594-600. doi: 10.1016/s0022-2143(96)90132-8.
10
Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock.
Shock. 2005 Sep;24(3):206-9. doi: 10.1097/01.shk.0000180074.69143.77.
本文引用的文献
1
Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility.
J Clin Invest. 1981 Jul;68(1):153-62. doi: 10.1172/jci110231.
2
Augmentation of selective monocyte functions in tuberculosis.
J Infect Dis. 1981 Nov;144(5):391-8. doi: 10.1093/infdis/144.5.391.
3
Antibodies to purified protein derivative in different immunoglobulin classes in the diagnosis of tuberculosis in man.
Int Arch Allergy Appl Immunol. 1983;70(1):25-9. doi: 10.1159/000233268.
4
The immune spectrum in patients with pulmonary tuberculosis.
Am Rev Respir Dis. 1981 May;123(5):556-9. doi: 10.1164/arrd.1981.123.5.556.
5
Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2.
J Exp Med. 1983 Dec 1;158(6):2165-70. doi: 10.1084/jem.158.6.2165.
6
Carnitine--metabolism and functions.
Physiol Rev. 1983 Oct;63(4):1420-80. doi: 10.1152/physrev.1983.63.4.1420.
7
The interference of antibiotics with antigen-specific antibody responses in man.
Int J Immunopharmacol. 1986;8(7):805-9. doi: 10.1016/0192-0561(86)90018-4.
8
The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay.
Am Rev Respir Dis. 1987 May;135(5):1137-51. doi: 10.1164/arrd.1987.135.5.1137.
9
10
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.
J Exp Med. 1986 May 1;163(5):1162-72. doi: 10.1084/jem.163.5.1162.
Zotero 插件